GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Green Planet Bioengineering Co Ltd (OTCPK:GPLB) » Definitions » EBIT per Share

Green Planet Bioengineering Co (Green Planet Bioengineering Co) EBIT per Share : $-0.00 (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Green Planet Bioengineering Co EBIT per Share?

Green Planet Bioengineering Co's EBIT per Share for the three months ended in Mar. 2024 was $0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.00.

During the past 5 years, the average EBIT per Share Growth Rate was -6.10% per year. During the past 10 years, the average EBIT per Share Growth Rate was 0.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Green Planet Bioengineering Co's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Green Planet Bioengineering Co was 20.60% per year. The lowest was -26.00% per year. And the median was 20.60% per year.

GPLB's 3-Year EBIT Growth Rate is not ranked *
in the Diversified Financial Services industry.
Industry Median: 8.9
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Green Planet Bioengineering Co's EBIT for the three months ended in Mar. 2024 was $-0.01 Mil.


Green Planet Bioengineering Co EBIT per Share Historical Data

The historical data trend for Green Planet Bioengineering Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Planet Bioengineering Co EBIT per Share Chart

Green Planet Bioengineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Green Planet Bioengineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Green Planet Bioengineering Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Green Planet Bioengineering Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

EBIT per Share(A: Dec. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.047/20.006
=-0.00

Green Planet Bioengineering Co's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

EBIT per Share(Q: Mar. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.006/20.006
=-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Green Planet Bioengineering Co  (OTCPK:GPLB) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Green Planet Bioengineering Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Green Planet Bioengineering Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Green Planet Bioengineering Co (Green Planet Bioengineering Co) Business Description

Traded in Other Exchanges
N/A
Address
20807 Biscayne Boulevard, Suite 203, Aventura, FL, USA, 33180
Green Planet Bioengineering Co Ltd is a shell company.
Executives
Shanyan Ou director, officer: VP of Sales 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Jian Chen director, officer: Chief Scientist 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Jianrong Zheng director 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Zhao 10 percent owner, officer: CHIEF EXECUTIVE OFFICER 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Yan Zhen 10 percent owner 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Cris Neely director, 10 percent owner, officer: President 18851 NE 29TH AVENUE, SUITE 700, AVENTURA CA 33180
Mondo Management Corp. 10 percent owner 61 BROADWAY, NEW YORK NY 10006
Gregory Sichenzia director, 10 percent owner SICHENZIA ROSS FRIEDMAN FERENCE LLP, 1065 AVENUE OF THE AMERICAS, 21ST FLOOR, NEW YORK NY 10018
Darrin M Ocasio director, 10 percent owner, officer: President C/O MONDO ACQUISITION II, 61 BROADWAY, 32ND FLOOR, NEW YORK NY 10006
Michael H Ference director, 10 percent owner, officer: Secretary C/O MONDO ACQUISITION II, 61 BROADWAY, 32ND FLOOR, NEW YORK NY 10006

Green Planet Bioengineering Co (Green Planet Bioengineering Co) Headlines

No Headlines